Rejected at 2:04 a.m. Nov, 01, 2023 ] by Ahmed7
Author: cataclysm17
Related Note: 1503263785726 1
Rationale for change

UpToDate recommends 12 months of rifampin and dapsone rather than the 6 months written on this card.

"For patients with tuberculoid disease, we favor treatment with dapsone (100 mg daily) and rifampicin (600 mg daily) for a duration 12 months. "

See: https://www.uptodate.com/contents/leprosy-treatment-and-prevention?search=leprosy%20treatment&source=search_result&selectedTitle=1~141&usage_type=default&display_rank=1#H310298018

I believe the 6 month figure only comes from the associated Sketchy video.

Rejection reason

sticking with amboss, comments

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::21_Leprosy #AK_Step2_v12::Original_decks::Dorian::im::uw::infectious_dz #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Other::AnKing_Image::Koshur::Leprosy #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Bugs #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::24_Pyrazinamide_Ethambutol_Dapsone_and_Clofazimine #AK_Step1_v12::#B&B::14_Infectious_Disease::02_Bacteria::08_Mycobacteria #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::22_Dapsone,_Rifamycins,_Clofazimine_(Leprosy_Drugs) #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::19_Mycobacteria::*Mycobacterium_Leprae #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::42_Mycobacterium_Leprae #AK_Other::AnKing_Image::!Subjects::Microbiology::Leprosy #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::ID #AK_Step1_v12::#Pixorize::04_Microbiology::01_Antibiotics/Antiparasitics::22_Dapsone #AK_Step2_v12::#AMBOSS::-R0Dpf #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::23_Rifamycins #AK_Other::AnKing_Image::Koshur #AK_Step2_v12::#Resources_by_rotation::IM::uw::infectious_disease::infectious_disease_dorian #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Rifamycins #AK_Step1_v12::#Bootcamp::Microbiology::34_Antibiotics::24_Pyrazinamide_Ethambutol_Dapsone_and_Clofazimine #AK_Step1_v12::#UWorld::COMLEX::24425 #PANCE::INFECTIOUS_DISEASE::mycobacterial_diseases #AK_Step1_v12::#UWorld::Step::1314 #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Infectious_Disease #AK_Step1_v12::#Pixorize::04_Microbiology::06_Bacteria-Gram_Indeterminate::05_Mycobacterium_leprae #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#AMBOSS::F-0g_i #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#Bootcamp::Microbiology::08_Mycobacteria::06_Mycobacterium_Leprae #AK_Step2_v12::#Resources_by_rotation::IM::uw::infectious_disease::infectious_disease_zanki #AK_Step1_v12::#SketchyMicro::01_Bacteria::08_Mycobacteria::02_Mycobacterium_Leprae #AK_Step1_v12::#Low/HighYield::1-HighYield